These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1643199)

  • 1. Thyroid hormones, body temperature, and antidepressant treatment.
    Höflich G; Kasper S; Danos P; Schmidt R
    Biol Psychiatry; 1992 Apr; 31(8):859-62. PubMed ID: 1643199
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effects.
    Kasper S; Dötsch M; Kick H; Vieira A; Möller HJ
    Eur Neuropsychopharmacol; 1993 Mar; 3(1):13-21. PubMed ID: 8471827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic sleep deprivation and antidepressant medication in patients with major depression.
    Kasper S; Kick H; Voll G; Vieira A
    Eur Neuropsychopharmacol; 1991 May; 1(2):107-11. PubMed ID: 1821699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.
    Kasper S; Voll G; Vieira A; Kick H
    Pharmacopsychiatry; 1990 May; 23(3):135-42. PubMed ID: 2115680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of fluvoxamine and maprotiline in depressed patients.
    Hewer W; Rost W; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 1995; 246(1):1-6. PubMed ID: 8773212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Maprotiline versus fluvoxamine: comparison of their effects on the hypothalamo-hypophyseal-thyroid axis].
    De Mendonça Lima CA; Vandel S; Bonin B; Bechtel P; Carron R
    Encephale; 1997; 23(1):48-55. PubMed ID: 9172968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation with fluvoxamine but not maprotiline improves negative symptoms in treated schizophrenia: evidence for a specific serotonergic effect from a double-blind study.
    Silver H; Shmugliakov N
    J Clin Psychopharmacol; 1998 Jun; 18(3):208-11. PubMed ID: 9617979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients.
    Mück-Seler D; Jakovljević M; Deanović Z
    J Affect Disord; 1991 Nov; 23(3):157-64. PubMed ID: 1774431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.
    Poelinger W; Haber H
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():47-50. PubMed ID: 2644340
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
    Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
    Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
    Fabre LF
    J Clin Psychiatry; 1985 Dec; 46(12):521-4. PubMed ID: 3905772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients.
    Vermeiden M; van den Broek WW; Mulder PG; Birkenhäger TK
    J Psychopharmacol; 2010 Apr; 24(4):497-502. PubMed ID: 19423613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with maprotiline.
    Kabes J; Dostal T; Roth Z
    Act Nerv Super (Praha); 1982 May; 24(2):93-8. PubMed ID: 7048837
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of maprotiline on target symptoms of depressive states].
    Faltus F
    Act Nerv Super (Praha); 1982 May; 24(2):99-100. PubMed ID: 7102230
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the effects of imipramine and fluvoxamine on the thyroid axis.
    Brady KT; Lydiard RB; Kellner CH; Joffe R; Laird LK; Morton WA; Steele TE
    Biol Psychiatry; 1994 Dec; 36(11):778-9. PubMed ID: 7858077
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized, double-blind study of fluoxetine and maprotiline in the treatment of major depression.
    de Jonghe F; Ravelli DP; Tuynman-Qua H
    Pharmacopsychiatry; 1991 Mar; 24(2):62-7. PubMed ID: 1852793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression.
    de Jonghe F; Swinkels J; Tuynman-Qua H
    Pharmacopsychiatry; 1991 Jan; 24(1):21-7. PubMed ID: 1901418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
    Gwirtsman HE; Ahles S; Halaris A; DeMet E; Hill MA
    J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison of mianserin and maprotiline in depressed medically ill elderly people.
    Schifano F; Garbin A; Renesto V; De Dominicis MG; Trinciarelli G; Silvestri A; Magni G
    Acta Psychiatr Scand; 1990 Mar; 81(3):289-94. PubMed ID: 2188479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.